Hologic (HOLX) Reports In-Line Q1 EPS

Hologic (NASDAQ: HOLX) reported Q1 EPS of $0.61, in-line with the analyst estimate of $0.61. Revenue for the quarter came in at $850.5 million versus the consensus estimate of $839.82 million.

GUIDANCE:

Hologic sees Q2 2020 EPS of $0.61-$0.63, versus the consensus of $0.63. Hologic sees Q2 2020 revenue of $770-780 million, versus the consensus of $811.39 million.

Hologic sees FY2020 EPS of $2.63-$2.67, versus the consensus of $2.61. Hologic sees FY2020 revenue of $3.238-3.268 billion, versus the consensus of $3.32 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer